全文获取类型
收费全文 | 1081篇 |
免费 | 71篇 |
国内免费 | 2篇 |
出版年
2023年 | 13篇 |
2022年 | 15篇 |
2021年 | 49篇 |
2020年 | 44篇 |
2019年 | 41篇 |
2018年 | 42篇 |
2017年 | 38篇 |
2016年 | 41篇 |
2015年 | 63篇 |
2014年 | 81篇 |
2013年 | 93篇 |
2012年 | 102篇 |
2011年 | 79篇 |
2010年 | 57篇 |
2009年 | 34篇 |
2008年 | 57篇 |
2007年 | 62篇 |
2006年 | 42篇 |
2005年 | 30篇 |
2004年 | 42篇 |
2003年 | 45篇 |
2002年 | 33篇 |
2001年 | 4篇 |
2000年 | 2篇 |
1998年 | 4篇 |
1997年 | 1篇 |
1996年 | 1篇 |
1995年 | 2篇 |
1994年 | 1篇 |
1992年 | 3篇 |
1991年 | 4篇 |
1990年 | 1篇 |
1989年 | 2篇 |
1988年 | 1篇 |
1985年 | 4篇 |
1983年 | 1篇 |
1982年 | 1篇 |
1981年 | 4篇 |
1980年 | 6篇 |
1978年 | 1篇 |
1976年 | 3篇 |
1967年 | 2篇 |
1966年 | 1篇 |
1965年 | 1篇 |
1963年 | 1篇 |
排序方式: 共有1154条查询结果,搜索用时 15 毫秒
1.
2.
R. Leila Reynald Stefaan Sansen C. David Stout Eric F. Johnson 《The Journal of biological chemistry》2012,287(53):44581-44591
To identify the structural features underlying the distinct substrate and inhibitor profiles of P450 2C19 relative to the closely related human enzymes, P450s 2C8 and 2C9, the atomic structure (Protein Data Bank code 4GQS) of cytochrome P450 2C19 complexed with the inhibitor (2-methyl-1-benzofuran-3-yl)-(4-hydroxy-3,5-dimethylphenyl)methanone (Protein Data Bank chemical component 0XV) was determined to 2.87 Å resolution by x-ray crystallography. The conformation of the peptide backbone of P450 2C19 is most similar to that of P450 2C8, but the substrate-binding cavity of P450 2C8 is much larger than that of P450 2C19 due to differences in the amino acid residues that form the substrate-binding cavities of the two enzymes. In contrast, the substrate-binding cavity of P450 2C19 is much more similar in size to that of the structure of the P450 2C9 flurbiprofen complex than to that of a modified P450 2C9 or that of P450 2C8. The cavities of the P450 2C19 0XV complex and the P450 2C9 flurbiprofen complex differ, however, because the helix B-C loops of the two enzymes are dissimilar. These conformational differences reflect the effects of adjacent structural elements that interact with the B-C loops and that differ between the two enzymes. The availability of a structure for 2C19 will facilitate computational approaches for predictions of substrate and inhibitor binding to this enzyme. 相似文献
3.
4.
Rasoul Ghasemi Leila Dargahi Ali Haeri Maryam Moosavi Zahurin Mohamed Abolhassan Ahmadiani 《Molecular neurobiology》2013,47(3):1045-1065
Arduous efforts have been made in the last three decades to elucidate the role of insulin in the brain. A growing number of evidences show that insulin is involved in several physiological function of the brain such as food intake and weight control, reproduction, learning and memory, neuromodulation and neuroprotection. In addition, it is now clear that insulin and insulin disturbances particularly diabetes mellitus may contribute or in some cases play the main role in development and progression of neurodegenerative and neuropsychiatric disorders. Focusing on the molecular mechanisms, this review summarizes the recent findings on the involvement of insulin dysfunction in neurological disorders like Alzheimer’s disease, Parkinson’s disease and Huntington’s disease and also mental disorders like depression and psychosis sharing features of neuroinflammation and neurodegeneration. 相似文献
5.
Leila J. Walker M.S. Joseph W. Landau M.D. Hisako Nishihara Sc.D. Victor D. Newcomer M.D. 《Mycopathologia》1965,27(3-4):301-304
Summary The level of haptoglobin was determined in control rats and in rats infected withC. immitis. The haptoglobin levels in the infected group were significantly higher than in those in the control group. The possibility that serial determinations may be of value in following the course of this disease is currently being investigated.This study was supported in part by USPHS Grants A1-06048-01, 5 T1 A1 52–06 and the Dermatologic Research Foundation of California, Inc. 相似文献
6.
Hamidreza Kheiri Manjili Leila Ma’mani Sharareh Tavaddod Maedeh Mashhadikhan Abbas Shafiee Hossein Naderi-Manesh 《PloS one》2016,11(3)
A novel design of gold-coated iron oxide nanoparticles was fabricated as a potential delivery system to improve the efficiency and stability of d, l-sulforaphane as an anticancer drug. To this purpose, the surface of gold-coated iron oxide nanoparticles was modified for sulforaphane delivery via furnishing its surface with thiolated polyethylene glycol-folic acid and thiolated polyethylene glycol-FITC. The synthesized nanoparticles were characterized by different techniques such as FTIR, energy dispersive X-ray spectroscopy, UV-visible spectroscopy, scanning and transmission electron microscopy. The average diameters of the synthesized nanoparticles before and after sulforaphane loading were obtained ∼ 33 nm and ∼ 38 nm, respectively, when ∼ 2.8 mmol/g of sulforaphane was loaded. The result of cell viability assay which was confirmed by apoptosis assay on the human breast cancer cells (MCF-7 line) as a model of in vitro-cancerous cells, proved that the bare nanoparticles showed little inherent cytotoxicity, whereas the sulforaphane-loaded nanoparticles were cytotoxic. The expression rate of the anti-apoptotic genes (bcl-2 and bcl-xL), and the pro-apoptotic genes (bax and bak) were quantified, and it was found that the expression rate of bcl-2 and bcl-xL genes significantly were decreased when MCF-7 cells were incubated by sulforaphane-loaded nanoparticles. The sulforaphane-loaded into the designed gold-coated iron oxide nanoparticles, acceptably induced apoptosis in MCF-7 cells. 相似文献
7.
Jamal S.M. Sabir Abdelfatteh El Omri Noor A. Shaik Babajan Banaganapalli Nahid H. Hajrah Houda Zrelli Leila Arfaoui Zuhier A. Awan Abdulkader M. Shaikh Omar Arif Mohammed Mona G. Alharbi Alawiah M. Alhebshi Robert K. Jansen Muhummadh Khan 《Saudi Journal of Biological Sciences》2019,26(7):1338-1343
Obesity is a multifactorial metabolic disorder characterized by low grade chronic inflammation. Rare and novel mutations in genes which are vital in several key pathways have been reported to alter the energy expenditure which regulates body weight. The TP53 or p53 gene plays a prominent role in regulating various metabolic activities such as glycolysis, lipolysis, and glycogen synthesis. Recent genome-wide association studies reported that tumor suppressor gene p53 variants play a critical role in the predisposition of type 2 diabetes and obesity. Till date, no reports are available from the Arabian population; hence the present study was intended to assess the association between p53 variants with risk of obesity development in the Saudi population. We have selected three p53 polymorphisms, rs1642785 (C > G), and rs9894946 (A > G), and rs1042522 (Pro72Arg; C > G) and assessed their association with obesity risk in the Saudi population. Phenotypic and biochemical parameters were also evaluated to check their association with p53 genotypes and obesity. Genotyping was carried out on 136 obese and 122 normal samples. We observed that there is significantly increased prevalence p52 Pro72Arg (rs1042522) polymorphism in obese persons when compared to controls at GG genotype in overall comparison (OR: 2.169, 95% CI: 1.086-4.334, p = 0.02716). Male obese subjects showed three-fold higher risk at GG genotype (OR: 3.275, 95% CI: 1.230-8.716, p = 0.01560) and two-fold risk at G allele (OR: 1.827, 95% CI: 1.128-2.958, p = 0.01388) of p53 variant Pro72Arg respectively. This variant has also shown significant influence on cholesterol, LDL level, and random insulin levels in obese subjects (p ≤ 0.05). In conclusion, p53 Pro72Arg variant is highly prevalent among obese individuals and may act as a genetic modifier for obesity development among Saudis. 相似文献
8.
Samadi Mitra Beigi Laleh Yadegari Fatemeh Ansari Alireza Madjid Majidzadeh-A Keivan Eskordi Maryam Farahmand Leila 《Genetica》2022,150(5):289-297
Genetica - Although predicting the effects of variants near intron-exon boundaries is relatively straightforward, predicting the functional Exon Splicing Enhancers (ESEs) and the possible effects... 相似文献
9.
10.
Fahimeh Ramezani Tehrani Seyed Ali Montazeri Farhad Hosseinpanah Leila Cheraghi Hadi Erfani Maryam Tohidi Fereidoun Azizi 《PloS one》2015,10(9)